Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.
Kao
David P
DP
Witteles
Ronald M
RM
Quon
Andrew
A
Wu
Joseph C
JC
Gambhir
Sanjiv Sam
SS
Fowler
Michael B
MB
D000818:Animals; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007333:Insulin Resistance; D009206:Myocardium / Q000378:metabolism*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*; D014665:Vasodilator Agents
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D014665:Vasodilator Agents; D000077154:Rosiglitazone; D005947:Glucose